Market cap
$0 Mln
Recently Viewed
Clear AllMarket cap
$0 Mln
Revenue (TTM)
$6 Mln
P/E Ratio
--
P/B Ratio
0
Div. Yield
0 %
Today’s Range
52 Week Range
Liquidity
Net Profit (TTM)
$-3 Mln
ROE
-1 %
ROCE
-- %
Industry P/E
24.57
EV/EBITDA
-2.7
Debt to Equity
0
Book Value
$1.3
EPS
$-7
Face value
--
Shares outstanding
13,960,740
CFO
$-24.57 Mln
EBITDA
$-40.86 Mln
Net Profit
$-96.50 Mln
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
BIMI International Medical (BIMI)
| 0.0 | -- | -- | -99.0 | -94.8 | -93.3 | -72.2 |
|
BSE Sensex
| -9.5 | 5.5 | -6.0 | -4.3 | 8.7 | 9.9 | 11.5 |
|
S&P Small-Cap 600#
| -5.8 | -5.3 | -13.7 | -6.3 | 5.3 | 3.0 | 5.5 |
|
Company
|
2023
|
2021
|
2020
|
2019
|
2018
|
2017
|
|---|---|---|---|---|---|---|
|
BIMI International Medical (BIMI)
| 78.0 | -69.5 | -47.6 | -79.7 | 1,497.2 | 11.5 |
|
S&P Small-Cap 600
| 13.9 | 25.3 | 9.6 | 20.9 | -9.7 | 11.7 |
|
BSE Sensex
| 18.7 | 22.0 | 15.8 | 14.4 | 5.9 | 27.9 |
Is there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Company |
Price ($) | Market Cap ($ Mln) | Revenue (TTM) | Net Profit (TTM) | OPM (%) | ROE (%) | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
|
BIMI International Medical (BIMI)
|
0.0 | 0.0 | 5.9 | -24.9 | -180.3 | -304.8 | -- | 0.0 |
| 12.5 | 3,993.9 | 2,323.3 | 44.1 | 12.3 | -- | 56.9 | 105.4 | |
| 40.9 | 5,233.8 | 1,003.8 | 22.4 | 6.8 | 7.5 | 227.4 | 14.1 | |
| 186.0 | 9,512.5 | 638.5 | -183.2 | -27.4 | -252.1 | -- | 107.7 | |
| 73.3 | 14,206.3 | 502.1 | -729.3 | -125.8 | 41.2 | -- | 123.7 | |
| 46.1 | 4,944.9 | 761.4 | 99.7 | 7.3 | 15 | 56.2 | 7.6 | |
| 22.8 | 11,181.1 | 4,715.0 | -232.0 | 0.9 | -3.7 | -- | 1.7 | |
| 231.3 | 4,634.3 | 268.1 | 124.5 | 60.0 | 13.5 | 37.7 | 4.6 | |
| 37.3 | 3,287.6 | 158.3 | -68.9 | -29.3 | -113 | -- | 73.8 | |
| 60.9 | 3,736.3 | 391.6 | -76.6 | -19.3 | -16.4 | -- | 8.2 |
BIMI Holdings Inc., together with its subsidiaries, engages in the retail and wholesale distribution of medical solution, and pharmaceutical and other healthcare products in the People's Republic of China and the United States. The company operates... through four segments: Medical Devices; Healthcare Products; Wholesale Pharmaceuticals; and Pharmacy Retail. The Pharmacy Retail segment offers prescription and OTC medicines; TCM; healthcare supplies; traditional Chinese medicines; and sundry items. The Wholesale Pharmaceuticals segment provides prescription; OTC medicines; TCM; healthcare supplies; and sundry items. The Medical Device segment distributes medical devices, including medical consumables. The Healthcare products segment offers dietary supplements comprising cardiovascular products; anti-insomnia and depression products; male aphrodisiac products; menopausal syndrome products; gout products; and immunity products. It sells its products through pharmacies; retail stores; private and government clinics; directly owned stores; third party pharmacies; hospitals; drug wholesalers; and medical device dealers. The company was formerly known as BIMI International Medical Inc. and changed its name to BIMI Holdings Inc. in January 2024. The company was incorporated in 2000 and is based in New York, New York. Read more
CEO & Director
Mr. Tiewei Song
CEO & Director
Mr. Tiewei Song
Headquarters
New York, NY
Website
Our rating system has guided millions of investors in the past 20 years.
The share price of BIMI International Medical Inc (BIMI) is $0.00 (NASDAQ) as of 24-Apr-2026 09:30 EDT. BIMI International Medical Inc (BIMI) has given a return of -94.81% in the last 3 years.
Since, TTM earnings of BIMI International Medical Inc (BIMI) is negative, P/E ratio is not available.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
|
2022
|
-0.16
|
0.91
|
|
2021
|
-0.01
|
0.05
|
|
2020
|
--
|
--
|
|
2019
|
--
|
--
|
|
2018
|
--
|
--
|
The 52-week high and low of BIMI International Medical Inc (BIMI) are Rs 0.04 and Rs 0.00 as of 26-Apr-2026.
BIMI International Medical Inc (BIMI) has a market capitalisation of $ 0 Mln as on 24-Apr-2026. As per SEBI classification, it is a Small Cap company.
Before investing in BIMI International Medical Inc (BIMI), assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.